Clinical outcomes after IL-6 blockade in patients with COVID-19 and HIV: a case series
Clinical outcomes after IL-6 blockade in patients with COVID-19 and HIV: a case series
About this item
Full title
Author / Creator
Publisher
England: BioMed Central
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central
Subjects
More information
Scope and Contents
Contents
In hospitalized people with HIV (PWH) there is an increased risk of mortality from COVID-19 among hospitalized PWH as compared to HIV-negative individuals. Evidence suggests that tocilizumab-a humanized monoclonal interleukin (IL)-6 receptor inhibitor (IL-6ri) antibody-has a modest mortality benefit when combined with corticosteroids in select hosp...
Alternative Titles
Full title
Clinical outcomes after IL-6 blockade in patients with COVID-19 and HIV: a case series
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_e6d9c2a55680454cab0266ce534330b9
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e6d9c2a55680454cab0266ce534330b9
Other Identifiers
ISSN
1742-6405
E-ISSN
1742-6405
DOI
10.1186/s12981-022-00430-x
